Was vaguely interesting -- until the parts about "racial heritage" and "the white man walking alone". Check out this guy's other posts for a surprise.
the end result of the public option is employer-based plans offloading their least valuable (and most vulnerable) customers onto the public option, leading to much higher costs for everyone. the abolition of private…
comp isn't above market rate. without equity or bonuses & with the long hours required, not sure what the upside is.
Nope. Since the dep array is empty, the effect only runs once after the first render, & the cleanup function returned from the effect only runs on unmount.
function Counter() { const [counter, setCounter] = React.useState(0); React.useEffect(() => { const interval = setInterval(() => setCounter(n => n + 1), 100); return () => clearInterval(interval); }, []) return (…
All the real money is already on the side of preserving the electoral college. You should examine why this is and reassess.
There are at least two currently-running candidates who do seem have the balls to directly confront the pharma industry! Why do you think there aren't?
Was vaguely interesting -- until the parts about "racial heritage" and "the white man walking alone". Check out this guy's other posts for a surprise.
the end result of the public option is employer-based plans offloading their least valuable (and most vulnerable) customers onto the public option, leading to much higher costs for everyone. the abolition of private…
comp isn't above market rate. without equity or bonuses & with the long hours required, not sure what the upside is.
Nope. Since the dep array is empty, the effect only runs once after the first render, & the cleanup function returned from the effect only runs on unmount.
function Counter() { const [counter, setCounter] = React.useState(0); React.useEffect(() => { const interval = setInterval(() => setCounter(n => n + 1), 100); return () => clearInterval(interval); }, []) return (…
All the real money is already on the side of preserving the electoral college. You should examine why this is and reassess.
There are at least two currently-running candidates who do seem have the balls to directly confront the pharma industry! Why do you think there aren't?